Literature DB >> 19050935

Increased chymase-positive mast cells in children with crescentic glomerulonephritis.

Hiroko Togawa1, Koichi Nakanishi, Yuko Shima, Mina Obana, Mayumi Sako, Kandai Nozu, Ryojiro Tanaka, Kazumoto Iijima, Norishige Yoshikawa.   

Abstract

Mast cell-derived chymase is an angiotensin II-forming enzyme that appears to be involved in tubulointerstitial fibrosis in the kidneys. Previous studies have shown that the level of chymase increases in grafted kidneys after rejection and in adult patients with diabetic nephropathy. However, the significance of chymase in children with renal diseases has not been investigated. Using immunohistochemistry, we have investigated chymase expression in biopsy samples of renal tissue from 104 children with kidney diseases, including rapidly progressive crescentic glomerulonephritis (n = 3), diabetic nephropathy (n = 2), allografted kidney (n = 3), membranoproliferative glomerulonephritis (n = 6), immunoglobulin A nephropathy (n = 33) and Henoch-Schönlein purpura nephritis (n = 23). Increased numbers of chymase-positive mast cells were observed in the renal cortex of all three patients with crescentic glomerulonephritis (mean 26.0/mm(2); range 19.3-36.8/mm(2)). Chymase-positive cells were also observed in the renal biopsy of an allografted kidney and in those from children with diabetic nephropathy. The mean number of chymase-positive cells in renal tissue samples characterized by each renal disease was significantly correlated with the mean intensity of the interstitial fibrosis in that same tissue sample (Spearman's rank correlation test p = 0.0013; rank correlation coefficient 0.84). These findings suggest that mast cell-derived chymase plays an important role in juvenile crescentic glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050935     DOI: 10.1007/s00467-008-1044-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2.

Authors:  Elena Tchougounova; Anders Lundequist; Ignacio Fajardo; Jan-Olof Winberg; Magnus Abrink; Gunnar Pejler
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

2.  Histological differences in new-onset IgA nephropathy between children and adults.

Authors:  Yohei Ikezumi; Toshiaki Suzuki; Naofumi Imai; Mitsuhiro Ueno; Ichiei Narita; Hiroshi Kawachi; Fujio Shimizu; David J Nikolic-Paterson; Makoto Uchiyama
Journal:  Nephrol Dial Transplant       Date:  2006-08-25       Impact factor: 5.992

3.  Mast cell chymase expression and mast cell phenotypes in human rejected kidneys.

Authors:  M Yamada; M Ueda; T Naruko; S Tanabe; Y S Han; Y Ikura; M Ogami; S Takai; M Miyazaki
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

4.  Mast cells in rapidly progressive glomerulonephritis.

Authors:  T Tóth; R Tóth-Jakatics; S Jimi; M Ihara; H Urata; S Takebayashi
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

5.  Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.

Authors:  Chie Miyake-Ogawa; Masanobu Miyazaki; Katsushige Abe; Takashi Harada; Yoshiyuki Ozono; Hideto Sakai; Takehiko Koji; Shigeru Kohno
Journal:  Am J Nephrol       Date:  2005-01-07       Impact factor: 3.754

6.  The Banff 97 working classification of renal allograft pathology.

Authors:  L C Racusen; K Solez; R B Colvin; S M Bonsib; M C Castro; T Cavallo; B P Croker; A J Demetris; C B Drachenberg; A B Fogo; P Furness; L W Gaber; I W Gibson; D Glotz; J C Goldberg; J Grande; P F Halloran; H E Hansen; B Hartley; P J Hayry; C M Hill; E O Hoffman; L G Hunsicker; A S Lindblad; Y Yamaguchi
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

Review 7.  Mast cells and inflammatory kidney disease.

Authors:  Ulrich Blank; Marie Essig; Lisa Scandiuzzi; Marc Benhamou; Yutaka Kanamaru
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

8.  Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis.

Authors:  T Ehara; H Shigematsu
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

9.  Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.

Authors:  Xiao R Huang; Wei Y Chen; Luan D Truong; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

Review 10.  Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system.

Authors:  N K Hollenberg; N D Fisher; D A Price
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

  10 in total
  2 in total

1.  Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.

Authors:  J M Zheng; G H Yao; Z Cheng; R Wang; Z H Liu
Journal:  Diabetologia       Date:  2011-12-01       Impact factor: 10.122

2.  Impact of Mast Cell Chymase on Renal Disease Progression.

Authors:  Haimanot Wasse; Nawazish Naqvi; Ahsan Husain
Journal:  Curr Hypertens Rev       Date:  2012-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.